comprehensive -WSS

comprehensive

author：knowledge 2025-09-30 21:07:42 - browse：799

Microsoft's head of research Peter Lee speaking at STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — Surging interest in generative AI among medical professionals since ChatGPT’s launch is perhaps a testament to its potential — but it could also lead clinicians, and patients to experiment with it before there is wider consensus on how to navigate its biases and other pitfalls, Microsoft’s head of research Peter Lee said Thursday at STAT’s Breakthrough Summit.

About a month after OpenAI — Microsoft has a significant financial stake in the company — launched its chatbot in 2022 on November 30, which happened to be Lee’s birthday, he got a note from a doctor friend who said he’d used it so his receptionist could file after-visit summaries for patients. While Lee and a handful of other doctors at Microsoft had been impressed with the GPT-4’s capabilities, they knew it had weaknesses.

“The emotions were really mixed. I mean we were thrilled,” he said, but then “just within minutes there’s a feeling of dread. We had already come to the realization that GPT-4 would be prone to issues, issues of bias, hallucination, mathematical and logical errors,” he said. “And so, there’s an immediate question: ‘Should we allow this to happen?’”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Lilly’s obesity pill cuts 15% of weight at highest dose in mid

WSS

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Tuskegee Airman Raymond Cassagnol dies at 102

The simple reason for the increase in autism diagnosis

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Psilocybin's anti

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Alkermes shareholders re

Ukrainian soldiers say they owe lives to US

Sports medicine is finally prioritizing gender equality

Ukrainian soldiers say they owe lives to US

ChatGPT in medicine: STAT answers readers' burning questions

Complete sequence of Y chromosome published for first time

In Memoriam: Notable people who died in 2023

In science, is the line between industry and academia shifting?

After affirmative action ruling, medical educators look to 'holistic review'

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

leisure time

ADA: All diabetes patients should be screened for liver condition

ADA: All diabetes patients should be screened for liver condition

What do new weight loss drugs mean for bariatric surgery?

What do new weight loss drugs mean for bariatric surgery?

What do new weight loss drugs mean for bariatric surgery?

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

knowledge

focus

focus

knowledge